Jailendra Singh
Stock Analyst at Truist Securities
(0.94)
# 3,923
Out of 5,090 analysts
185
Total ratings
29%
Success rate
-23.54%
Average return
Main Sectors:
Stocks Rated by Jailendra Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRVA Privia Health Group | Reiterates: Buy | $30 → $31 | $23.84 | +30.03% | 8 | Nov 10, 2025 | |
| EVH Evolent Health | Maintains: Buy | $16 → $10 | $3.94 | +153.81% | 8 | Nov 10, 2025 | |
| IQV IQVIA Holdings | Reiterates: Buy | $235 → $265 | $225.85 | +17.33% | 17 | Oct 29, 2025 | |
| PHR Phreesia | Maintains: Buy | $35 → $36 | $20.29 | +77.43% | 7 | Sep 8, 2025 | |
| HIMS Hims & Hers Health | Maintains: Hold | $48 → $37 | $39.20 | -5.61% | 11 | Aug 18, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $187 → $234 | $185.80 | +25.94% | 10 | Jul 25, 2025 | |
| MEDP Medpace Holdings | Maintains: Hold | $298 → $436 | $548.12 | -20.46% | 5 | Jul 23, 2025 | |
| WAY Waystar Holding | Maintains: Buy | $50 → $51 | $34.35 | +48.47% | 3 | Jul 17, 2025 | |
| PGNY Progyny | Maintains: Hold | $24 → $27 | $24.02 | +12.41% | 10 | Jul 17, 2025 | |
| DOCS Doximity | Maintains: Hold | $52 → $61 | $45.93 | +32.81% | 9 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $48 | $50.04 | -4.08% | 1 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $10 → $9 | $7.59 | +18.58% | 16 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6.5 → $5.5 | $2.71 | +102.95% | 12 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $12 → $7.5 | $4.01 | +87.03% | 7 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $46 | $22.07 | +108.43% | 5 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $261 → $210 | $242.00 | -13.22% | 7 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $14 | $9.44 | +48.31% | 1 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6.4 → $6.5 | $0.65 | +896.63% | 8 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $13 | $3.81 | +241.21% | 11 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $42 → $43 | $2.59 | +1,560.23% | 6 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $30 → $24 | $2.46 | +875.61% | 2 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $14 → $4 | $1.39 | +187.77% | 4 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $58 | $198.83 | -70.83% | 2 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $90 → $45 | $3.03 | +1,385.15% | 7 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $230 → $333 | $808.62 | -58.82% | 6 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $9 | $2.58 | +248.84% | 2 | May 19, 2021 |
Privia Health Group
Nov 10, 2025
Reiterates: Buy
Price Target: $30 → $31
Current: $23.84
Upside: +30.03%
Evolent Health
Nov 10, 2025
Maintains: Buy
Price Target: $16 → $10
Current: $3.94
Upside: +153.81%
IQVIA Holdings
Oct 29, 2025
Reiterates: Buy
Price Target: $235 → $265
Current: $225.85
Upside: +17.33%
Phreesia
Sep 8, 2025
Maintains: Buy
Price Target: $35 → $36
Current: $20.29
Upside: +77.43%
Hims & Hers Health
Aug 18, 2025
Maintains: Hold
Price Target: $48 → $37
Current: $39.20
Upside: -5.61%
ICON Public Limited Company
Jul 25, 2025
Maintains: Buy
Price Target: $187 → $234
Current: $185.80
Upside: +25.94%
Medpace Holdings
Jul 23, 2025
Maintains: Hold
Price Target: $298 → $436
Current: $548.12
Upside: -20.46%
Waystar Holding
Jul 17, 2025
Maintains: Buy
Price Target: $50 → $51
Current: $34.35
Upside: +48.47%
Progyny
Jul 17, 2025
Maintains: Hold
Price Target: $24 → $27
Current: $24.02
Upside: +12.41%
Doximity
Jul 17, 2025
Maintains: Hold
Price Target: $52 → $61
Current: $45.93
Upside: +32.81%
Jun 16, 2025
Initiates: Buy
Price Target: $48
Current: $50.04
Upside: -4.08%
May 27, 2025
Maintains: Hold
Price Target: $10 → $9
Current: $7.59
Upside: +18.58%
Apr 10, 2025
Maintains: Hold
Price Target: $6.5 → $5.5
Current: $2.71
Upside: +102.95%
Apr 10, 2025
Maintains: Hold
Price Target: $12 → $7.5
Current: $4.01
Upside: +87.03%
Mar 18, 2025
Maintains: Buy
Price Target: $50 → $46
Current: $22.07
Upside: +108.43%
Jan 13, 2025
Maintains: Hold
Price Target: $261 → $210
Current: $242.00
Upside: -13.22%
Jul 2, 2024
Maintains: Buy
Price Target: $17 → $14
Current: $9.44
Upside: +48.31%
May 24, 2024
Maintains: Hold
Price Target: $6.4 → $6.5
Current: $0.65
Upside: +896.63%
May 4, 2022
Maintains: Neutral
Price Target: $16 → $13
Current: $3.81
Upside: +241.21%
Feb 28, 2022
Maintains: Neutral
Price Target: $42 → $43
Current: $2.59
Upside: +1,560.23%
Feb 24, 2022
Maintains: Neutral
Price Target: $30 → $24
Current: $2.46
Upside: +875.61%
Feb 8, 2022
Downgrades: Neutral
Price Target: $14 → $4
Current: $1.39
Upside: +187.77%
Feb 4, 2022
Maintains: Neutral
Price Target: $60 → $58
Current: $198.83
Upside: -70.83%
Jan 7, 2022
Downgrades: Underperform
Price Target: $90 → $45
Current: $3.03
Upside: +1,385.15%
Jan 7, 2022
Upgrades: Outperform
Price Target: $230 → $333
Current: $808.62
Upside: -58.82%
May 19, 2021
Maintains: Neutral
Price Target: $10 → $9
Current: $2.58
Upside: +248.84%